Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Multimodal Analgesia for Supratentorial Craniotomy
NCT07441421Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine and liposomal bupivacaine in postoperative pain and postoperative delirium (POD) (4 arms), sponsored by Beijing Tiantan Hospital. Primary endpoints: Incidence of persistent incisional pain at 3 months and Incidence of postoperative delirium. Started Mar 2026; status: recruiting.
02
Drugs
dexmedetomidineliposomal bupivacaine
03
Conditions
postoperative painpostoperative delirium (POD)
Beyond the preview
Go deeper on NCT07441421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07441421.